However, while FDFT1 acts as a tumor suppressor by negatively regulating AKT/mTOR/HIF1α signaling in CRC cells (Weng et al., 2020), SQLE activates the β‐catenin oncogenic pathway. The gene discussed is MTOR; the disease is neoplasm.